Related Experiment Video
Updated: Mar 31, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis
Naohiro Yonemoto1,2, Shiro Tanaka3, Toshi A Furukawa4,5
1Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8553, Japan. nyonemoto@gmail.com.
Background:
SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for unipolar major depressive episodes. The trial has three steps and two randomizations. Step I randomization compares the minimum and the maximum dosing strategy for the first-line antidepressant. Step II randomization compares the continuation, augmentation or switching strategy for the second-line antidepressant treatment. Step III is a naturalistic continuation phase. The original protocol was published in 2011, and we hereby report its updated protocol including the statistical analysis plan.
Results:
We implemented two important changes to the original protocol. One is about the required sample size, reflecting the smaller number of dropouts than had been expected. Another is in the organization of the primary and secondary outcomes in order to make the report of the main trial results as pertinent and interpretable as possible for clinical practices. Due to the complexity of the trial, we plan to report the main results in two separate reports, and this updated protocol and the statistical analysis plan have laid out respective primary and secondary outcomes and their analyses. We will convene the blind interpretation committee before the randomization code is broken.
Conclusion:
This paper presents the updated protocol and the detailed statistical analysis plan for the SUN(^_^)D trial in order to avoid reporting bias and data-driven results.
Trial Registration:
ClinicalTrials.gov: NCT01109693 (registered on 21 April 2010).
Insights
The SUN(^_^)D trial updates its protocol for major depressive episodes, optimizing first- and second-line antidepressant strategies. This pragmatic mega-trial ensures unbiased reporting of treatment effectiveness.
Area of Science:
- Psychiatry and Clinical Psychology
- Pharmacology and Pharmaceutical Sciences
Background:
- The SUN(^_^)D trial investigates optimal treatment strategies for unipolar major depressive episodes.
- It employs a pragmatic mega-trial design with three steps and two randomizations for first- and second-line antidepressant treatments.
- The trial was registered on ClinicalTrials.gov (NCT01109693) in April 2010.
Purpose of the Study:
- To present the updated protocol and statistical analysis plan for the SUN(^_^)D trial.
- To refine the reporting of primary and secondary outcomes for enhanced clinical relevance.
- To minimize reporting bias and data-driven results in the trial analysis.
Main Methods:
- An assessor-blinded, parallel-group, multicenter pragmatic mega-trial design.
- Step I: Minimum vs. maximum dosing for first-line antidepressants.
- Step II: Continuation, augmentation, or switching strategies for second-line antidepressants; Step III: Naturalistic continuation phase.
Main Results:
- Two key protocol changes were implemented: sample size adjustment due to lower dropout rates and refined outcome organization.
- The updated protocol details primary and secondary outcomes and their analyses for two separate main results reports.
- A blind interpretation committee will convene before randomization codes are broken.
Conclusions:
- This updated protocol and statistical analysis plan facilitate unbiased and interpretable reporting of the SUN(^_^)D trial findings.
- The modifications aim to enhance the clinical applicability of the results regarding antidepressant treatment strategies.
- The trial is structured to provide robust evidence on optimizing depression management.
More Related Videos
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Depression: Overview
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Dosage Regimens: Designs and Approaches